New Nordic Healthbrands AB (publ) (STO:NNH)
Sweden · Delayed Price · Currency is SEK 17.40
+0.05 (0.29%)
Sep 2, 2026, 4:49 PM CET
STO:NNH Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 585.82 | 576.36 | 550.31 | 533.85 | 487.5 | 514.85 | |
Revenue Growth | 3.50% | 4.74% | 3.08% | 9.51% | -5.31% | 14.39% |
Cost of Revenue | 214.18 | 205.95 | 195.61 | 185.62 | 169 | 164.8 |
Gross Profit | 371.63 | 370.42 | 354.69 | 348.23 | 318.5 | 350.05 |
Selling, General & Admin | 355.06 | 352.8 | 356.51 | 349.5 | 321.61 | 320.57 |
Operating Expenses | 357.67 | 355.27 | 359.14 | 351.4 | 323.25 | 321.5 |
Operating Income | 13.97 | 15.15 | -4.45 | -3.17 | -4.75 | 28.55 |
Interest Expense | -1.52 | -2.13 | -2.71 | -2.26 | -1.53 | -0.59 |
Interest & Investment Income | 0.03 | 0.02 | 0.03 | 0.08 | 1.11 | 0 |
Currency Exchange Gain (Loss) | - | - | - | -0.47 | - | - |
Other Non Operating Income (Expenses) | -0.52 | -0.53 | 0.37 | -0.1 | - | -0 |
Pretax Income | 11.96 | 12.51 | -6.76 | -5.91 | -5.17 | 27.96 |
Income Tax Expense | 4.12 | 4.32 | 0.94 | 0.28 | -2.34 | 6.65 |
Net Income | 7.84 | 8.2 | -7.7 | -6.19 | -2.82 | 21.3 |
Net Income to Common | 7.84 | 8.2 | -7.7 | -6.19 | -2.82 | 21.3 |
Net Income Growth | 58.41% | - | - | - | - | 19.92% |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 1.27 | 1.32 | -1.24 | -1.00 | -0.46 | 3.44 |
EPS (Diluted) | 1.27 | 1.32 | -1.24 | -1.00 | -0.46 | 3.44 |
EPS Growth | 58.41% | - | - | - | - | 19.92% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 5.21 | 7.57 | -6.62 | 25.88 | -17.04 | -8.88 |
Free Cash Flow Per Share | 0.84 | 1.22 | -1.07 | 4.18 | -2.75 | -1.43 |
Dividend Per Share | 0.250 | 0.250 | - | - | - | 1.250 |
Dividend Growth | - | - | - | - | - | -16.67% |
Gross Margin | 63.44% | 64.27% | 64.45% | 65.23% | 65.33% | 67.99% |
Operating Margin | 2.38% | 2.63% | -0.81% | -0.59% | -0.97% | 5.54% |
Profit Margin | 1.34% | 1.42% | -1.40% | -1.16% | -0.58% | 4.14% |
Free Cash Flow Margin | 0.89% | 1.31% | -1.20% | 4.85% | -3.50% | -1.72% |
EBITDA | 15.78 | 16.81 | -2.81 | -1.94 | -3.68 | 29.34 |
EBITDA Margin | 2.69% | 2.92% | -0.51% | -0.36% | -0.76% | 5.70% |
D&A For EBITDA | 1.81 | 1.67 | 1.63 | 1.22 | 1.07 | 0.79 |
EBIT | 13.97 | 15.15 | -4.45 | -3.17 | -4.75 | 28.55 |
EBIT Margin | 2.38% | 2.63% | -0.81% | -0.59% | -0.97% | 5.54% |
Effective Tax Rate | 34.41% | 34.50% | - | - | - | 23.80% |
Revenue as Reported | 576.36 | 576.36 | 550.31 | 533.85 | 487.5 | 514.85 |